C26H32N4O4S
496.6 g/mol
APIDanger
Selexipag
CAS475086-01-2
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Selexipag is a pharmaceutical raw material and a prodrug that is converted in the body to its active metabolite, ACT-333679. It is primarily used in the manufacturing of compounds targeting the prostacyclin receptor pathway for research and pharmaceutical applications.
active pharmaceutical ingredient for prostacyclin receptor agonistsresearch compound for vasodilation studiespharmaceutical intermediate for pulmonary arterial hypertension research
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 475086-01-2
Related Compounds
ReferenceSame Category
Sorafenib tosylate
CAS475207-59-1
pharmaceutical raw material
ReferenceSame Category
Adw-742
CAS475488-23-4
pharmaceutical raw material
ReferenceSame Category
GSK 621659A
CAS475489-15-7
pharmaceutical raw material
ReferenceSame Category
NVP-AEW541
CAS475489-16-8
pharmaceutical raw material
Referencesame scaffold
5-bromo-2,3-diphenylpyrazine
CAS243472-70-0
research compound
Referencesame scaffold
5-chloro-2,3-diphenylpyrazine
CAS41270-66-0
Research reagent
Safety Reference
Danger
H302Harmful if swallowed
H360May damage fertility or the unborn child
H373May cause damage to organs through prolonged or repeated exposure
Identifiers
IUPAC Name
2-[4-[(5,6-diphenylpyrazin-2-yl)-propan-2-ylamino]butoxy]-N-methylsulfonylacetamide
InChIKey
QXWZQTURMXZVHJ-UHFFFAOYSA-N
SMILES
CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)C1=CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3
Synonyms (18)
- Selexipag (JAN/USAN/INN)
- NS-304(Selexipag)
- NS-304;ACT-293987
- Selexipag
- Selexipag (Standard)
- Selexipag TITRATION PACK
- Selexipag(NS-304)
- Uptravi
- Uptravi (TN)
- Uptravi Titration Pack
- selexipagum